Lexicon Pharmaceuticals Inc (LXRX) — Cash Flow Quality Index

Latest as of June 2025: 5.23x

Lexicon Pharmaceuticals Inc (LXRX) has a Cash Flow Quality Index of 5.23x as of June 2025. Operating cash flow of $16.99 Million exceeds net income of $3.25 Million, indicating high earnings quality where cash backs reported profits. Explore Lexicon Pharmaceuticals Inc (LXRX) cash conversion ratio to assess how effectively this company generates cash.

Cash Flow Quality Index

5.23x

Operating CF / Net Income

Operating Cash Flow

$16.99 Million

USD

Net Income

$3.25 Million

USD

Data as of

Jun 2025

Most recent filing

Lexicon Pharmaceuticals Inc Cash Flow Quality Index (2019–2019)

Historical Cash Flow Quality Index for Lexicon Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Lexicon Pharmaceuticals Inc (LXRX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Lexicon Pharmaceuticals Inc (2019–2019)

Year-by-year earnings quality comparison for Lexicon Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is Lexicon Pharmaceuticals Inc worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2019	0.87x	$113.81 Million	$130.13 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.